Cash boost for clinical trials.
The European and Developing Countries Clinical Trials Partnership The European and Developing Countries Clinical Trials Partnership or EDCTP is a partnership between the European Union (EU), Norway, Switzerland and developing countries and other donors, as well as the pharmaceutical industry, to enable clinical trials and the development (EDCTP EDCTP European-Developing Countries Clinical Trial Partnership ) is injecting over [euro]80m ($124m) into African medical
research. The Science and Development Network reports that the money
will be spent on malaria malaria, infectious parasitic disease that can be either acute or chronic and is frequently recurrent. Malaria is common in Africa, Central and South America, the Mediterranean countries, Asia, and many of the Pacific islands. research, the development of HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. and TB
treatments and for the provision of vaccines and microbicides. The
combined sum will be the largest approved by the EDCTP since it was
established in 2003, and should reinforce the EU's partnership with
sub-Saharan Africa. The EDCTP links 14 member states of the EU as well
as Norway and Switzerland to countries in sub-Saharan Africa, largely by
providing resources for joint clinical trials, capacity building and
networking activities.
COPYRIGHT 2008 IC Publications Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion